<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SLCYAAQE/ee22aa38-8125-425a-9f91-2ee03adc1168/PDF"><dcterms:extent>85 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SLCYAAQE/dc873dd4-02d4-490b-a506-a90ecb4cc1d9/TEXT"><dcterms:extent>40 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-SLCYAAQE"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>1996</dcterms:issued><dc:creator>Dernovšek, Mojca Zvezdana</dc:creator><dc:creator>Šteblaj, Anton</dc:creator><dc:creator>Tavčar, Rok</dc:creator><dc:format xml:lang="sl">letnik:35</dc:format><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">str. 567-579</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:7374553</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-SLCYAAQE</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="en">drug</dc:subject><dc:subject xml:lang="sl">duševni bolniki</dc:subject><dc:subject xml:lang="sl">psihoze</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">zdravila</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q179661" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Petinštirideset let nevroleptikov|</dc:title><dc:description xml:lang="sl">Neuroleptics were discovered by chance in 1950. Since then, a substantial bodyof clinical experiences has been collected. The understanding of mechanisms of their action stimulated the development of new theories about the causes of mental disorders. Neuroleptics are symptomatic drugs, because they do not affect the principal causes of mental disorders. The authors give a brief historical review of the development of neuroleptics, and discuss in detail their pharmacokinetics, mechanisms of action and side effects. Clinicalefficacy of neuroleptics is illustrated by a number of examples, and some guidelines for a rational use of these drugs are given. Polypharmacy should be avoided and the dosage individualised. The patient's response to treatment should be evaluated no sooner than four to six weeks after the initiation of therapy. The authors review the latest achievements in the search for new neuroleptics, which are excepted to treat more effectively negative manifestations of schizophrenia and to cause fewer side effects</dc:description><dc:description xml:lang="sl">Nevroleptike so slučajno odkrili leta 1950. Z leti so se pri njihovi uporabi nabrale obsežne klinične izkušnje. Znanje o mehanizmu njihovega delovanja je omogočilo razvoj novih domnev o vzroku duševnih motenj. Dejansko so nevroleptiki še vedno simptomatska zdravila, saj ne delujejo na vzroke duševnih motenj. V preglednem članku avtorji kratko opisujejo odkritje in razvoj nevroleptikov, podrobneje pa obravnavajo mehanizme njihovega delovanja,farmakokinetiko in stranske učinke. Podani so številni dokazi o učinkovitosti nevroleptikov pri zdravljenju psihoz. Obsežno so navedena načelaracionalne uporabe nevroleptikov. Izogibati se je potrebno sočasni uporabi več zdravil, odmerke je treba prilagajati posameznemu bolniku, ocena učinka zdravila pa je možna šele po štirih do šestih tednih. Avtorji kritično obravnavajo najnovejša prizadevanja pri iskanju novih zdravil, ki naj bi bila uspešnejša pri zdravljenju negativnih simptomov shizofrenije, hkrati pa naj biimela manj stranskih učinkov</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-SLCYAAQE"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-SLCYAAQE" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-SLCYAAQE/ee22aa38-8125-425a-9f91-2ee03adc1168/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-SLCYAAQE/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-SLCYAAQE" /></ore:Aggregation></rdf:RDF>